Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Feb;39(1):55-59.
doi: 10.12669/pjms.39.1.6850.

Comparison of different ratios of cefoperazone/sulbactam in patients with pyelonephritis

Weizhong Jiang  1 , Lili Cai  2
Affiliations

Comparison of different ratios of cefoperazone/sulbactam in patients with pyelonephritis

Weizhong Jiang et al. Pak J Med Sci. 2023 Jan-Feb.

Abstract

Objective: To compare the clinical efficacy of different ratios of cefoperazone/sulbactam in the treatment of patients with pyelonephritis.

Methods: In this retrospective study clinical records of patients with pyelonephritis treated in Huzhou Traditional Chinese Medicine Hospital from July 2020 to July 2021 were collected,. It included 55 patients who received cefoperazone/sulbactam 2:1 treatment (Control group) and 57 patients who received 1 cefoperazone/sulbactam 1:1 treatment (Observation group). Clinical response, inflammatory reaction and bacterial clearance were compared between the two groups.

Results: The levels of C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-8 (IL-8) and leukocyte count (WBC) in the observation group were lower than those in the control group (P<0.05). The total efficacy of the Observation-group was 92.98%, higher than 80.00% of the control group (P<0.05). Fifty-eight strains of bacteria were isolated from the Control-group and 59 strains from the Observation-group. The bacterial clearance rates were 65.52% (38/58) and 83.05% (49/59), respectively. The differences were statistically significant (P<0.05).

Conclusions: The clinical efficacy of 1:1 ratio of cefoperazone/sulbactam in the treatment of patients with pyelonephritis was superior that of 2:1 ratio. This ratio allows to fully utilize the antibacterial effect of cefoperazone, with a significant decrease in inflammation markers and an improvement in bacterial clearance.

Keywords: Anti-inflammatory; Bacterial clearance; Cefoperazone/sulbactam; Pyelonephritis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Tartar AS, Balin SO. Geriatric urinary tract infections:The value of laboratory parameters in estimating the need for bacteremia and Intensive Care Unit. Pak J Med Sci. 2019;35(1):215–219. doi:10.12669/pjms.35.1.97. - PMC - PubMed
    1. Li Y, Xie J, Chen L, Meng T, Liu L, Hao R, et al. Treatment efficacy of tigecycline in comparison to cefoperazone/ sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections. Pak J Pharm Sci. 2020;33(1):161–168. - PubMed
    1. Ku YH, Yu WL. Cefoperazone/sulbactam:new composites against multiresistant gram negative bacteria? Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2021;88:104707. doi:10.1016/j.meegid.2021.104707. - PubMed
    1. Sader HS, Carvalhaes CG, Streit JM, Castanheira M, Flamm RK. Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;91:32–37. doi:10.1016/j.ijid.2019.11.006. - PubMed
    1. Guclu E, Kaya G, Ogutlu A, Karabay O. The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections. J Chemother Florence Italy. 2020;32(3):118–123. doi:10.1080/1120009X.2020.1730087. - PubMed

LinkOut - more resources